Publications:

Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.

Heliyon

Deng, Qinfang Q; Xie, Boxiong B; Wu, Leilei L; Ji, Xianxiu X; Li, Chao C; Feng, Li L; Fang, Qiyu Q; Bao, Yuchen Y; Li, Jialu J; Jin, Shengnan S; Ding, Chunming C; Li, Yixue Y; Zhou, Songwen S

Publication Date: 2018-12

Variant appearance in text: EGFR: Y813F

PubMed Link: 30603682

Variant Present in the following documents:

• mmc2.xlsx, sheet 1

View BVdb publication page

Ubiquitination switches EphA2 vesicular traffic from a continuous safeguard to a finite signalling mode.

Nature Communications

Sabet, Ola O; Stockert, Rabea R; Xouri, Georgia G; Brüggemann, Yannick Y; Stanoev, Angel A; Bastiaens, Philippe I H PIH

Publication Date: 2015-08-21

Variant appearance in text: EGFR: Y813F

PubMed Link: 26292967

Variant Present in the following documents:

• Main text
• ncomms9047.pdf

View BVdb publication page